🚀
Enjoy a 7-Day Free Trial Thru May 06, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
Day One Biopharmaceuticals Inc (NAS:DAWN)
News
Day One Biopharmaceuticals Inc
1
NAS
:DAWN (USA) Â
$ 14.92
+1.71 (+12.94%)
10:08 PM EST
P/E:
At Loss
P/B:
3.76
Market Cap:
$ 1.30B
Enterprise V:
$ 937.73M
Volume:
3.60M
Avg Vol (2M):
1.22M
Warning! GuruFocus detected 2 Severe warning signs with DAWN.
Try a 7-Day Free Trial
to check it out.
Volume:
3.60M
Market Cap $:
1.30B
PE Ratio:
At Loss
Avg Vol (2M):
1.22M
Enterprise Value $:
937.73M
PB Ratio:
3.76
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Day One Biopharmaceuticals Inc (NAS:DAWN) Stock News, Headlines & Updates
Day One Biopharmaceuticals Inc Stock News from GuruFocus
Total 42
1
2
Apr 23, 2024
Day One's OJEMDAâ„¢ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
Marketwired
•
3:00pm
Feb 28, 2024
Day One Biopharmaceuticals Inc (DAWN) Reports Q4 and Full Year 2023 Financial Results
GuruFocus Research
•
3:32am
Feb 06, 2024
Day One Biopharmaceuticals Inc Conference Call Transcript
GuruFocus Research
•
2:05pm
Day One Biopharmaceuticals Inc Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib Conference Call Transcript
GuruFocus Research
•
2:05pm
Nov 06, 2023
Day One Biopharmaceuticals Inc (DAWN) Reports Q3 2023 Financial Results and Corporate Progress
GuruFocus Research
•
4:16pm
Sep 12, 2023
Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
GlobeNewswire
•
11:00pm
Sep 11, 2023
Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
Marketwired
•
8:00am
Aug 16, 2023
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
Marketwired
•
7:00am
Aug 07, 2023
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
Marketwired
•
4:00pm
May 19, 2023
Insider Alert: An Insider Just Sold Day One Biopharmaceuticals Inc Shares
GuruFocus Research
•
1:00pm
May 18, 2023
This Insider Just Sold Shares of Day One Biopharmaceuticals Inc
GuruFocus Research
•
11:10am
Jan 25, 2023
Insider Alert: An Insider Just Sold Day One Biopharmaceuticals Inc Shares
GuruFocus Research
•
12:30pm
Jan 24, 2023
Insider Alert: An Insider Just Sold Day One Biopharmaceuticals Inc Shares
GuruFocus Research
•
12:30pm
Jan 08, 2023
Day One Announces Topline Data from Pivotal Phase 2 FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade Glioma
Stock market mentor
•
4:00pm
Dec 20, 2022
Day One to Present at the 41st Annual J.P. Morgan Healthcare Conference
Value_Insider
•
7:00am
Nov 17, 2022
Day One to Participate in the Piper Sandler 34th Annual Healthcare Conference
Value_Insider
•
6:00am
Nov 11, 2022
Day One Announces Upcoming Presentations at 2022 Society for Neuro-Oncology Annual Meeting
Value_Insider
•
6:00am
Nov 07, 2022
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
Value_Insider
•
4:01pm
Aug 04, 2022
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
PurpleRose
•
4:00pm
Jul 15, 2022
Day One Announces Pricing of Upsized Public Offering of Common Stock
PurpleRose
•
8:30pm
Jul 12, 2022
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
PurpleRose
•
4:30pm
Jul 11, 2022
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
PurpleRose
•
5:08pm
Jun 25, 2022
Day One Announces Pricing of Upsized Public Offering of Common Stock
GuruFocusNews
•
8:26pm
Jun 22, 2022
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
GuruFocusNews
•
4:25pm
Jun 21, 2022
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
GuruFocusNews
•
5:07pm
Jun 15, 2022
Day One Announces Pricing of Upsized Public Offering of Common Stock
GuruFocusNews
•
7:25pm
Jun 14, 2022
Day One Announces Proposed Public Offering of Common Stock
GuruFocusNews
•
7:23am
Jun 12, 2022
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
GuruFocusNews
•
4:23pm
Jun 01, 2022
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
GuruFocusNews
•
5:06pm
May 22, 2022
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
GuruFocusNews
•
5:05pm
May 12, 2022
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
GuruFocusNews
•
4:33pm
Apr 06, 2022
Day One to Present at the 21st Annual Needham Virtual Healthcare Conference
GuruFocusNews
•
8:00am
Feb 28, 2022
Day One to Participate in the Cowen 42nd Annual Health Care Conference
GuruFocusNews
•
4:01pm
Feb 17, 2022
Summit Rock Advisors, LP Buys Day One Biopharmaceuticals Inc, Monday.Com, Dyne Therapeutics Inc, Sells iShares Russell 2000 Value ETF
GuruFocusNews
•
1:38pm
Jan 05, 2022
Day One to Present at the 40th Annual J.P. Morgan Healthcare Conference
GuruFocusNews
•
8:01am
Nov 22, 2021
Day One Announces First Patient Dosed in Phase 2 Monotherapy Study in RAF-altered Solid Tumors
GuruFocusNews
•
6:00am
Nov 18, 2021
Day One to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
GuruFocusNews
•
7:00am
Nov 08, 2021
Day One Reports Third Quarter 2021 Financial Results and Corporate Progress
Don Li2
•
4:01pm
Nov 03, 2021
Day One Announces Presentation at 2021 Connective Tissue Oncology Society (CTOS) Virtual Annual Meeting
Don Li2
•
7:00am
Jul 27, 2021
Day One Receives FDA Rare Pediatric Disease Designation for DAY101 for the Treatment of Pediatric Low-Grade Glioma
Marketwired
•
6:00am
Total 42
1
2
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news